key: cord-0882914-jdsk16tp
authors: Sauza-Sosa, Julio C.; Rojas-Gomez, Cesar A.; Montes de Oca-Sandoval, Marco A.; Hernandez-Rendon, Edgar; Lima-Linares, Rafael; Camarena-Alejo, Gilberto
title: Acute Cor Pulmonale in Critically Patient with COVID-19 resolved with Veno-Arterio-Venous ECMO Right Heart Failure in COVID-19
date: 2021-02-27
journal: CASE (Phila)
DOI: 10.1016/j.case.2021.02.004
sha: 0a9cd574445b51940807b3a37b4248d81d5ba79e
doc_id: 882914
cord_uid: jdsk16tp

nan

A 38-year-old male diagnosed with COVID-19 was hospitalized for 20 days receiving treatment with levofloxacin, lopinavir / ritonavir, tocilizumab, and steroid; however, he did not show clinical signs of improvement and was transferred to our medical center.

At the emergency department, he presented with respiratory failure. On examination, his temperature was 98.6 o F (37.0 o C), blood pressure 110/60mmHg, heart rate 115 beats per minute, respiratory rate 35 breaths per minute and his oxygen saturation 75% while wearing a non-rebreather mask at 10 liters per minute. Physical examination showed bilateral coarse crackles in lower lungs field. The remainder of physical examination was normal. Endotracheal intubation was performed successfully.

Laboratory test showed leukocytosis 14 700/µL, pH 6.96, pCO 2 198.3 mm Hg, pO 2 61 mm Hg, Sat O 2 70.3%, HCO 3 28.6 mmol/L, BE -2.5 mmol/L, lactate 3.52 mmol/L, D-dimer level of 183 ng/mL, NT pro-BNP 941 pg/mL, hs-Troponin I 43.8 ng/mL

The electrocardiogram showed sinus tachycardia with right axis deviation. Computed tomography of the chest revealed multiple bilateral ground glass opacities associated to consolidations with superimposed irregular septa (Figure 1 ).

The patient presented with refractory severe hypoxemia and hypercapnia after 12 hours of mechanical ventilation, therefore it was decided to initiate treatment with VV-ECMO. The incidence of RV disfunction in ARDS is 10-25% and is associated with greater mortality 5 , thus assessing rapid and efficient recovery of RV function which could be of paramount importance in this clinical context.

In our clinical case, we decided to switch from VV-ECMO to VAV-ECMO due to the presence refractory hypoxemia and new onset RV failure. The etiology of RV disfunction is a common finding in patients with COVID-19 [6] [7] [8] . While no single causative factor has been elucidated, there are several potential aetiologic factors which have been shown to increase RV afterload and impair RV contractility. In this case, RV disfunction probably was multifactorial (thrombosis, vascular alterations, hypoxia, hypercapnia, effects of mechanical ventilation, direct myocardial injury).

During placement of VV-ECMO the diagnosis of RV disfunction was based on the presence of right ventricular enlargement and contractility impairment, therefore, it was decided to switch to VAV-ECMO. In our clinical case, improvement in RV function demonstrated by transesophageal echocardiogram was clearly evident. After cannulation, the patient presented hemodynamic improvement, RV structural improvements, and increase in partial pressure of Oxygen (Table 2) .

With VAV-ECMO, arterialized blood flow is divided using a Y-connector for one cannula returning blood toward the central aorta, and one for returning blood to the right atrium. During VAV-ECMO support, repetitive echocardiography and continuous oxygenation surveillance were mandatory to assess tissue oxygenation, and right ventricular filling and function.

VAV modality may allow for the preservation of RV preload while concomitantly improving overall oxygenation and eliminating differential hypoxemia. This phenomenon has been 

Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact

Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation

Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19

Right Ventricular Dilation in Hospitalized Patients With COVID-19 Infection

Cannulation strategies in adult veno-arterial and veno-venous extracorporeal membrane oxygenation: Techniques, limitations, and special considerations

Application of veno-arterialvenous extracorporeal membrane oxygenation in differential hypoxia